Diagnostics & Research (industry)

Compare top 5 →
Q-Score53
Market Cap$921.7B
Aggregate P/E46.88
Dividend Yield0.29%
1Y Return+31.0%
Advancing (1M)52.27%
AI summary

Returns

+31.0%over the year
Cap-weightedMedianUp
1M+5.9%+0.6%52%
3M+21.8%+14.9%70%
YTD+24.2%+14.5%66%
1Y+31.0%+18.7%64%

Led by the largest companies: the median company returned +18.7%.

Returns by horizon and breadth

This month's movers

Leaders
  • MYGNMyriad Genetics, Inc.+42.4%
  • CDNACareDx, Inc.+34.5%
  • IDXXIDEXX Laboratories, Inc.+29.6%
  • ICLRICON Public Limited Company+22.0%
  • GRALGRAIL, Inc.+18.7%
Laggards
  • VCYTVeracyte, Inc.-46.8%
  • FRNMFreenome, Inc.-28.9%
  • WGSGeneDx Holdings Corp.-18.6%
  • ILMNIllumina, Inc.-17.0%
  • ADPTAdaptive Biotechnologies Corporation-10.1%
Every horizon's leaders and laggards

News sentiment

Open News

Largest companies

The map and every share

Size

Revenue$175.7B
Earnings$19.7B
Companies44
Concentration (HHI)0.19
Size and financials

Q-Score profile

53/ 100
Every score and metric

Valuation

Aggregate P/E46.88
Aggregate P/S5.25
Dividend yield0.29%
Earnings yield2.13%
Net margin11.19%
The valuation map

Revenue exposure

Outside the US47.83%
From Greater China—
Largest customer (avg.)—
Revenue covered56.14%
Size and financials